Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17,276 | $15,806 | $15,529 | $15,624 |
| % Growth | 9.3% | 1.8% | -0.6% | – |
| Cost of Goods Sold | $3,124 | $3,557 | $3,419 | $3,828 |
| Gross Profit | $14,152 | $12,249 | $12,110 | $11,796 |
| % Margin | 81.9% | 77.5% | 78% | 75.5% |
| R&D Expenses | $3,997 | $4,048 | $3,621 | $4,584 |
| G&A Expenses | $0 | $0 | $0 | $291 |
| SG&A Expenses | $2,599 | $2,649 | $2,552 | $2,691 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,400 |
| Other Operating Expenses | $0 | $0 | $0 | $173 |
| Operating Expenses | $6,596 | $6,697 | $6,173 | $7,448 |
| Operating Income | $7,556 | $5,552 | $5,937 | $4,348 |
| % Margin | 43.7% | 35.1% | 38.2% | 27.8% |
| Other Income/Exp. Net | -$811 | -$553 | -$34 | -$178 |
| Pre-Tax Income | $6,745 | $4,999 | $5,903 | $4,170 |
| Tax Expense | $958 | $571 | $818 | $426 |
| Net Income | $5,785 | $4,427 | $5,079 | $3,743 |
| % Margin | 33.5% | 28% | 32.7% | 24% |
| EPS | 2.32 | 1.77 | 2.02 | 1.48 |
| % Growth | 31.1% | -12.4% | 36.5% | – |
| EPS Diluted | 2.32 | 1.76 | 2.01 | 1.48 |
| Weighted Avg Shares Out | 2,498 | 2,503 | 2,516 | 2,541 |
| Weighted Avg Shares Out Dil | 2,498 | 2,513 | 2,531 | 2,541 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $69 | $109 | $146 |
| Interest Expense | $238 | $305 | $313 | $328 |
| Depreciation & Amortization | $1,154 | $1,119 | $1,099 | $1,197 |
| EBITDA | $8,137 | $6,423 | $7,315 | $5,695 |
| % Margin | 47.1% | 40.6% | 47.1% | 36.5% |